[ad_1] Primary safety and tolerability endpoint met AP-101 prolonged survival and delayed need for ventilatory support after 12 months of treatment Functional stabilization and reduced neurofilament biomarkers observed in study participants with elevated misfolded SOD1 […]
Trending Stories
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
[ad_1] SAN FRANCISCO, Dec. 5, 2025 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) today announced that the Organization and Compensation Committee of Nektar’s Board of Directors granted non-qualified stock options to purchase an aggregate of 18,310 […]
STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Lawsuit
[ad_1] NEW YORK, Dec. 5, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement […]
CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
[ad_1] NEW YORK, Dec. 5, 2025 /PRNewswire/ — S&P Dow Jones Indices (“S&P DJI”) will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open […]
Salt Lake City Oculoplastic Surgeon Dr. Kian Eftekhari to Present Innovative Ptosis Technique at International ABAM Conference
[ad_1] Renowned eyelid specialist Dr. Kian Eftekhari will share his groundbreaking 5-minute ptosis operation with plastic surgeons from around the world at the 18th American-Brazilian Aesthetic Meeting in Park City, Utah. SALT LAKE CITY, Dec. […]














